You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
|
|---|---|
| Published in |
BMC Neurology, February 2009
|
| DOI | 10.1186/1471-2377-9-6 |
| Pubmed ID | |
| Authors |
Sibilia Quilici, Jeremy Chancellor, Mickael Löthgren, Dominique Simon, Gérard Said, Trong Kim Le, Ana Garcia-Cebrian, Brigitta Monz |
| Abstract |
Few direct head-to-head comparisons have been conducted between drugs for the treatment of diabetic peripheral neuropathic pain (DPNP). Approved or recommended drugs in this indication include duloxetine (DLX), pregabalin (PGB), gabapentin (GBP) and amitriptyline (AMT). We conducted an indirect meta-analysis to compare the efficacy and tolerability of DLX with PGB and GBP in DPNP, using placebo as a common comparator. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 2 | 1% |
| India | 1 | <1% |
| United Kingdom | 1 | <1% |
| Nigeria | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 187 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 25 | 13% |
| Student > Postgraduate | 21 | 11% |
| Student > Ph. D. Student | 19 | 10% |
| Student > Bachelor | 18 | 9% |
| Other | 17 | 9% |
| Other | 54 | 28% |
| Unknown | 40 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 83 | 43% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 8% |
| Agricultural and Biological Sciences | 10 | 5% |
| Psychology | 6 | 3% |
| Nursing and Health Professions | 5 | 3% |
| Other | 25 | 13% |
| Unknown | 49 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2022.
All research outputs
#2,651,581
of 23,426,104 outputs
Outputs from BMC Neurology
#267
of 2,501 outputs
Outputs of similar age
#13,585
of 174,570 outputs
Outputs of similar age from BMC Neurology
#3
of 7 outputs
Altmetric has tracked 23,426,104 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,570 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.